CSR Draft Report Proposes New Panel To Review Clinical Oncology Research
In Brief: NBCC Plans Meetings On Quality Of Care, Potential Environmental Causes Of Disease
Clinical Research: Enough Studies Done, Time For Solutions, CSR Report Says
In Congress: Gore, Democrats Rally For Anti-Tobacco Legislation
Letter to the Editors: Loss Of ET2 Would Be Disheartening, Member Of Study Section Says
Trending Stories
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- Peter F. Garrett to people with cancer: Your story has power
- What NHS-Galleri taught us—and what it didn’t
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”









